Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
98
2025
1919
9.560
 Why?
Anti-Asthmatic Agents
28
2025
273
3.350
 Why?
Adrenal Cortex Hormones
28
2025
501
3.330
 Why?
Forced Expiratory Volume
19
2019
484
1.550
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
1048
1.350
 Why?
Severity of Illness Index
20
2020
2905
0.970
 Why?
Administration, Inhalation
25
2025
594
0.960
 Why?
Anti-Inflammatory Agents
10
2016
479
0.870
 Why?
Albuterol
5
2015
75
0.840
 Why?
Bronchodilator Agents
12
2016
196
0.830
 Why?
Lung Transplantation
10
2017
323
0.810
 Why?
Budesonide
14
2016
56
0.800
 Why?
Remote Consultation
4
2025
60
0.750
 Why?
Nedocromil
11
2016
23
0.720
 Why?
Humans
129
2025
141267
0.700
 Why?
Nasal Polyps
1
2021
61
0.690
 Why?
Self Report
3
2023
860
0.680
 Why?
Endpoint Determination
2
2020
77
0.670
 Why?
Pharmacogenetics
2
2015
168
0.670
 Why?
Food Hypersensitivity
1
2022
182
0.610
 Why?
Sinusitis
1
2021
239
0.590
 Why?
Virus Diseases
1
2021
215
0.580
 Why?
Lung
7
2019
4129
0.580
 Why?
Glucocorticoids
4
2022
533
0.570
 Why?
Physicians
2
2021
929
0.560
 Why?
Symptom Assessment
1
2019
131
0.550
 Why?
Hospitalization
13
2020
2272
0.550
 Why?
Sleep Apnea, Obstructive
1
2021
319
0.520
 Why?
Androstadienes
3
2012
74
0.510
 Why?
Bone Density
2
2014
496
0.500
 Why?
Child
53
2022
22342
0.500
 Why?
Disease Progression
14
2020
2798
0.500
 Why?
Oxygen Inhalation Therapy
4
2020
184
0.490
 Why?
Managed Care Programs
8
2008
140
0.490
 Why?
Male
82
2025
70063
0.480
 Why?
Emergency Service, Hospital
9
2013
2197
0.480
 Why?
Precision Medicine
1
2020
435
0.470
 Why?
Adult
47
2025
39203
0.470
 Why?
Female
81
2025
75729
0.450
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
27
0.440
 Why?
Cost Savings
1
2015
86
0.440
 Why?
Practice Patterns, Physicians'
7
2020
1335
0.430
 Why?
Patient Reported Outcome Measures
1
2018
452
0.430
 Why?
Peak Expiratory Flow Rate
2
2011
25
0.400
 Why?
Cost-Benefit Analysis
7
2022
612
0.400
 Why?
Middle Aged
40
2025
34597
0.400
 Why?
Phenotype
6
2025
3177
0.390
 Why?
Comorbidity
4
2021
1672
0.360
 Why?
Academic Medical Centers
3
2024
529
0.350
 Why?
Surveys and Questionnaires
14
2022
5937
0.340
 Why?
Adolescent
37
2019
22064
0.340
 Why?
Medical Records Systems, Computerized
3
2008
96
0.330
 Why?
Administration, Oral
6
2021
824
0.330
 Why?
Mentors
1
2012
213
0.330
 Why?
Quality of Life
12
2023
3021
0.330
 Why?
Respiratory Function Tests
10
2015
560
0.320
 Why?
United States
23
2022
15245
0.320
 Why?
Faculty, Medical
1
2012
292
0.310
 Why?
Interprofessional Relations
3
2021
282
0.310
 Why?
Child, Preschool
31
2016
11473
0.300
 Why?
Treatment Outcome
16
2025
11194
0.300
 Why?
Spirometry
8
2020
260
0.300
 Why?
Child Development
1
2014
496
0.300
 Why?
Group Practice
1
2008
6
0.290
 Why?
Anti-Allergic Agents
2
2008
42
0.280
 Why?
Oxygen
3
2018
992
0.280
 Why?
Aged
22
2022
24798
0.270
 Why?
Computer Simulation
1
2012
1012
0.270
 Why?
Dyspnea
3
2022
258
0.260
 Why?
Randomized Controlled Trials as Topic
8
2020
1605
0.250
 Why?
Drug Utilization
4
2005
166
0.250
 Why?
Primary Health Care
5
2025
1756
0.240
 Why?
Primary Graft Dysfunction
2
2017
34
0.240
 Why?
Quality Assurance, Health Care
1
2008
318
0.240
 Why?
Follow-Up Studies
17
2017
5213
0.240
 Why?
Bronchiolitis Obliterans
3
2017
65
0.230
 Why?
Gift Giving
1
2005
9
0.230
 Why?
Respiratory Sounds
1
2006
109
0.230
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.230
 Why?
Allergists
2
2022
11
0.230
 Why?
Genetic Testing
1
2008
464
0.230
 Why?
Delivery of Health Care
2
2021
950
0.220
 Why?
Medication Adherence
2
2023
512
0.210
 Why?
Retrospective Studies
18
2024
16373
0.210
 Why?
Specialization
2
2025
130
0.210
 Why?
Cohort Studies
14
2013
5802
0.210
 Why?
Time Factors
10
2020
6971
0.210
 Why?
Natural Language Processing
1
2025
103
0.210
 Why?
Leadership
2
2022
391
0.210
 Why?
Massachusetts
5
2016
176
0.210
 Why?
Antibodies, Monoclonal
2
2008
1472
0.200
 Why?
Medicine
1
2025
125
0.200
 Why?
Genetic Variation
1
2008
995
0.200
 Why?
Rhinitis, Allergic, Perennial
1
2003
22
0.200
 Why?
Steroids
8
2011
163
0.190
 Why?
Recurrence
5
2013
1108
0.190
 Why?
Genetic Predisposition to Disease
2
2025
2373
0.190
 Why?
Health Status
1
2008
822
0.190
 Why?
Predictive Value of Tests
9
2012
2072
0.190
 Why?
Beclomethasone
1
2022
9
0.190
 Why?
Multicenter Studies as Topic
4
2018
367
0.190
 Why?
Young Adult
11
2019
13667
0.180
 Why?
Prevalence
4
2022
2793
0.180
 Why?
Models, Theoretical
4
2007
583
0.180
 Why?
Tiotropium Bromide
2
2018
5
0.180
 Why?
Desensitization, Immunologic
1
2022
95
0.180
 Why?
Nebulizers and Vaporizers
2
2020
68
0.180
 Why?
Biomarkers
3
2021
4179
0.170
 Why?
Patient Preference
1
2023
204
0.170
 Why?
Social Class
2
2022
269
0.170
 Why?
Churg-Strauss Syndrome
1
2020
27
0.160
 Why?
Bronchoconstriction
3
2011
28
0.160
 Why?
Pulmonologists
1
2020
14
0.160
 Why?
Capacity Building
1
2021
59
0.160
 Why?
Granulomatosis with Polyangiitis
1
2020
46
0.160
 Why?
Muscarinic Antagonists
1
2020
30
0.160
 Why?
Agammaglobulinemia
1
2020
36
0.160
 Why?
Electronic Health Records
2
2025
1131
0.160
 Why?
Physician-Patient Relations
2
2021
580
0.160
 Why?
Practice Guidelines as Topic
5
2020
1543
0.150
 Why?
Risk Factors
12
2018
10482
0.150
 Why?
Air Pollution, Indoor
2
2002
180
0.150
 Why?
Treatment Adherence and Compliance
1
2019
27
0.150
 Why?
Exercise Test
1
2022
623
0.150
 Why?
Receptors, IgE
2
2009
44
0.140
 Why?
Prognosis
8
2017
4077
0.140
 Why?
Vitamin D
2
2012
392
0.140
 Why?
Allergens
1
2021
401
0.140
 Why?
Fossil Fuels
1
1997
10
0.140
 Why?
Alemtuzumab
1
2017
15
0.130
 Why?
Photopheresis
1
2017
9
0.130
 Why?
Hypersensitivity
1
2020
260
0.130
 Why?
Drug Prescriptions
2
2011
265
0.130
 Why?
Biological Products
1
2020
239
0.130
 Why?
Emergency Medical Services
2
2007
650
0.130
 Why?
Respiration
1
2017
211
0.130
 Why?
Respiration Disorders
1
1997
79
0.130
 Why?
Physicians, Primary Care
3
2021
225
0.130
 Why?
Drug Combinations
3
2012
365
0.120
 Why?
Statistics, Nonparametric
1
2017
432
0.120
 Why?
Drug Therapy, Combination
5
2020
1042
0.120
 Why?
Immunomodulation
1
2017
101
0.120
 Why?
Drug Monitoring
1
2020
398
0.120
 Why?
Socioeconomic Factors
4
2022
1312
0.120
 Why?
Breath Tests
2
2008
77
0.120
 Why?
Aged, 80 and over
6
2019
7947
0.120
 Why?
Scopolamine Derivatives
1
2015
3
0.120
 Why?
Tobacco Smoke Pollution
2
2010
238
0.120
 Why?
Patient Admission
1
2018
203
0.120
 Why?
Embolism, Fat
1
2015
11
0.120
 Why?
Immunoglobulin G
1
2020
899
0.120
 Why?
Cholinergic Antagonists
1
2015
24
0.120
 Why?
Transplants
1
2015
38
0.120
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
99
0.120
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
8
0.120
 Why?
Carcinoma, Bronchogenic
1
2015
20
0.110
 Why?
Genomics
2
2018
812
0.110
 Why?
Referral and Consultation
1
2021
797
0.110
 Why?
Longitudinal Studies
6
2017
2923
0.110
 Why?
Overweight
2
2011
587
0.110
 Why?
Graft Rejection
2
2013
546
0.110
 Why?
Respiratory Tract Infections
2
2012
386
0.110
 Why?
Ambulatory Care Information Systems
2
2005
5
0.110
 Why?
Postoperative Complications
2
2017
2824
0.110
 Why?
Telemedicine
1
2023
888
0.110
 Why?
Prednisolone
1
2014
68
0.110
 Why?
Guideline Adherence
3
2020
557
0.100
 Why?
Risk
4
2015
904
0.100
 Why?
Education, Medical, Continuing
2
2005
128
0.100
 Why?
Environmental Exposure
3
2006
578
0.100
 Why?
Airway Obstruction
1
2015
164
0.100
 Why?
Forecasting
1
2015
383
0.100
 Why?
Bronchial Hyperreactivity
3
2010
104
0.100
 Why?
Transplantation
1
2013
33
0.100
 Why?
Quality Improvement
1
2022
1239
0.100
 Why?
Office Visits
4
2011
95
0.100
 Why?
Insurance Claim Review
1
2013
85
0.100
 Why?
Peer Group
2
2012
247
0.100
 Why?
Medicare
2
2022
812
0.090
 Why?
Double-Blind Method
5
2010
1980
0.090
 Why?
Growth
1
2012
52
0.090
 Why?
Cytomegalovirus Infections
2
2012
197
0.090
 Why?
Costs and Cost Analysis
1
2013
219
0.090
 Why?
Research
1
2015
431
0.090
 Why?
Methacholine Chloride
3
2008
50
0.090
 Why?
Metered Dose Inhalers
1
2012
13
0.090
 Why?
Cost of Illness
3
2003
311
0.090
 Why?
Drug Dosage Calculations
1
2011
26
0.090
 Why?
Feedback
1
2012
178
0.090
 Why?
Antibodies, Monoclonal, Humanized
2
2008
911
0.090
 Why?
Logistic Models
5
2017
2095
0.090
 Why?
Mycoses
1
2012
86
0.090
 Why?
Antifungal Agents
1
2012
144
0.090
 Why?
Body Height
1
2012
200
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
9
0.090
 Why?
Multivariate Analysis
7
2017
1505
0.090
 Why?
Professional Role
1
2012
165
0.090
 Why?
Medication Errors
1
2012
96
0.090
 Why?
Morbidity
2
2022
320
0.090
 Why?
Epidemiologic Studies
1
2011
68
0.080
 Why?
Mycobacterium
1
2012
111
0.080
 Why?
Obesity
3
2015
3001
0.080
 Why?
Pneumococcal Vaccines
1
2012
138
0.080
 Why?
Diagnostic Errors
1
2012
174
0.080
 Why?
Patient Readmission
1
2016
709
0.080
 Why?
Secondary Prevention
1
2012
240
0.080
 Why?
Program Development
1
2012
364
0.080
 Why?
Drug Resistance
1
2011
149
0.080
 Why?
Probability
1
2011
308
0.080
 Why?
Vitamin D Deficiency
1
2012
187
0.080
 Why?
Lung Diseases
1
2017
793
0.080
 Why?
Chi-Square Distribution
2
2017
523
0.080
 Why?
Bronchial Provocation Tests
2
2008
50
0.080
 Why?
Fluticasone
2
2008
56
0.080
 Why?
Decision Support Techniques
2
2012
432
0.080
 Why?
Pragmatic Clinical Trials as Topic
2
2020
127
0.080
 Why?
Incidence
5
2020
2800
0.080
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
28
0.080
 Why?
Vital Capacity
4
2017
306
0.080
 Why?
Immunoglobulin E
2
2008
331
0.080
 Why?
Ambulatory Care
2
2011
587
0.080
 Why?
Lectins, C-Type
1
2009
63
0.080
 Why?
Algorithms
1
2017
1764
0.080
 Why?
Proportional Hazards Models
1
2012
1269
0.070
 Why?
Health Services
2
2007
116
0.070
 Why?
Odds Ratio
4
2017
1057
0.070
 Why?
Medication Therapy Management
1
2010
78
0.070
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1396
0.070
 Why?
Surgical Wound Infection
1
2012
321
0.070
 Why?
Smoking
3
2017
1573
0.070
 Why?
Acute Disease
1
2011
1012
0.070
 Why?
Pandemics
3
2022
1658
0.070
 Why?
Kaplan-Meier Estimate
3
2016
912
0.070
 Why?
Cross-Sectional Studies
6
2010
5653
0.070
 Why?
Vitamin K Epoxide Reductases
1
2008
11
0.070
 Why?
Cytochrome P-450 CYP2C9
1
2008
19
0.070
 Why?
Eosinophil Cationic Protein
1
2008
9
0.070
 Why?
Mixed Function Oxygenases
1
2008
48
0.070
 Why?
Program Evaluation
1
2012
919
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
47
0.070
 Why?
Adrenergic beta-Agonists
1
2008
98
0.070
 Why?
Genetic Techniques
1
2008
67
0.070
 Why?
Quality-Adjusted Life Years
2
2006
112
0.070
 Why?
Trastuzumab
1
2008
98
0.070
 Why?
Markov Chains
2
2006
123
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
24
0.070
 Why?
State Health Plans
1
2008
33
0.070
 Why?
Cost Sharing
1
2008
19
0.070
 Why?
Smoking Cessation
1
2012
431
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
52
0.070
 Why?
Reimbursement Mechanisms
1
2008
82
0.070
 Why?
Chronic Disease
3
2017
1812
0.070
 Why?
Omalizumab
1
2007
40
0.070
 Why?
Exercise Tolerance
2
2022
281
0.070
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
363
0.070
 Why?
Interviews as Topic
1
2011
841
0.070
 Why?
Factor Analysis, Statistical
1
2008
295
0.070
 Why?
Warfarin
1
2008
168
0.060
 Why?
Health Surveys
2
2006
511
0.060
 Why?
Antiviral Agents
1
2012
747
0.060
 Why?
Influenza Vaccines
1
2012
551
0.060
 Why?
Databases, Factual
1
2012
1446
0.060
 Why?
Health Services Accessibility
2
2021
1021
0.060
 Why?
Animals, Domestic
1
2006
16
0.060
 Why?
Lung Diseases, Interstitial
1
2013
653
0.060
 Why?
Tomography, X-Ray Computed
1
2017
2765
0.060
 Why?
Animals
2
2025
37642
0.060
 Why?
Physicians, Family
2
2004
192
0.060
 Why?
Biomedical Research
1
2012
681
0.060
 Why?
Eosinophils
1
2008
325
0.060
 Why?
Health Benefit Plans, Employee
1
2005
27
0.060
 Why?
Database Management Systems
1
2005
51
0.060
 Why?
Health Policy
1
2008
382
0.060
 Why?
Models, Biological
1
2012
1826
0.060
 Why?
Hip Fractures
1
2006
86
0.060
 Why?
Patients
1
2006
179
0.060
 Why?
Insurance Coverage
1
2006
240
0.050
 Why?
Utilization Review
1
2004
41
0.050
 Why?
Infant
3
2008
9801
0.050
 Why?
Patient Education as Topic
3
2005
773
0.050
 Why?
Body Mass Index
3
2015
2377
0.050
 Why?
Gene Expression Profiling
1
2011
1769
0.050
 Why?
Clinical Competence
1
2012
1197
0.050
 Why?
Medicaid
1
2008
446
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
656
0.050
 Why?
Mass Screening
1
2012
1304
0.050
 Why?
Nitric Oxide
1
2008
898
0.050
 Why?
Sex Factors
3
2016
2054
0.050
 Why?
Anticoagulants
1
2008
725
0.050
 Why?
Attitude to Health
1
2006
451
0.050
 Why?
Vaccination
1
2012
1468
0.050
 Why?
Case Management
1
2003
66
0.050
 Why?
Clinical Trials as Topic
2
2005
1036
0.050
 Why?
Anti-Bacterial Agents
2
2004
1865
0.050
 Why?
Choice Behavior
1
2004
171
0.050
 Why?
Puerto Rico
1
2022
54
0.050
 Why?
Parents
3
2006
1440
0.050
 Why?
Symptom Flare Up
1
2022
38
0.050
 Why?
Sputum
1
2004
311
0.050
 Why?
Academies and Institutes
1
2022
54
0.040
 Why?
Circadian Rhythm
1
2006
509
0.040
 Why?
Lung Neoplasms
1
2015
2555
0.040
 Why?
Health Services Research
1
2004
402
0.040
 Why?
Minority Groups
1
2003
278
0.040
 Why?
Survival Rate
2
2016
1973
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
77
0.040
 Why?
Electronics
1
2021
74
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
112
0.040
 Why?
Sample Size
1
2020
126
0.040
 Why?
Efficiency
1
2021
101
0.040
 Why?
Health Care Reform
1
2021
109
0.040
 Why?
Schools, Medical
1
2021
152
0.040
 Why?
Risk Assessment
3
2020
3515
0.040
 Why?
Patient Selection
2
2020
685
0.040
 Why?
Language
1
2022
309
0.040
 Why?
Patient Compliance
2
2016
608
0.040
 Why?
Stress, Psychological
1
2007
1122
0.040
 Why?
Time
1
2019
87
0.040
 Why?
Cluster Analysis
2
2014
518
0.040
 Why?
Health Education
1
2002
360
0.040
 Why?
Quality of Health Care
1
2003
647
0.040
 Why?
Poland
1
2017
35
0.030
 Why?
Republic of Korea
1
2017
41
0.030
 Why?
Bronchitis, Chronic
1
2017
24
0.030
 Why?
Cooperative Behavior
1
2021
455
0.030
 Why?
Patient-Centered Care
1
2003
536
0.030
 Why?
Sensitivity and Specificity
3
2013
1974
0.030
 Why?
Nitrogen Dioxide
1
1997
45
0.030
 Why?
Geography
1
2018
199
0.030
 Why?
Long-Term Care
1
2018
110
0.030
 Why?
Aftercare
1
2019
220
0.030
 Why?
Monitoring, Physiologic
2
2012
287
0.030
 Why?
Self Concept
1
2019
259
0.030
 Why?
Netherlands
1
2016
87
0.030
 Why?
Pediatrics
1
2005
1099
0.030
 Why?
Antineoplastic Agents
1
2008
2163
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
129
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
10
0.030
 Why?
Formoterol Fumarate
1
2015
7
0.030
 Why?
Perception
1
2019
375
0.030
 Why?
Salmeterol Xinafoate
1
2015
22
0.030
 Why?
Ethanolamines
1
2015
15
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
33
0.030
 Why?
Treatment Failure
1
2016
354
0.030
 Why?
Feasibility Studies
1
2020
1025
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2061
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2132
0.030
 Why?
Education
1
2015
108
0.030
 Why?
Self Efficacy
1
2019
404
0.030
 Why?
Postoperative Period
1
2016
360
0.030
 Why?
Age Factors
3
2008
3292
0.030
 Why?
Fatal Outcome
1
2015
308
0.030
 Why?
Immunosuppressive Agents
2
2015
855
0.030
 Why?
Biopsy
2
2013
1070
0.030
 Why?
Pilot Projects
1
2020
1815
0.030
 Why?
Combined Modality Therapy
1
2017
1243
0.030
 Why?
Patient Acceptance of Health Care
1
2021
876
0.030
 Why?
Gene Expression
1
2018
1492
0.030
 Why?
Echinocandins
1
2012
8
0.020
 Why?
Telephone
2
2005
180
0.020
 Why?
Lipopeptides
1
2012
14
0.020
 Why?
Aspergillosis
1
2012
22
0.020
 Why?
Amphotericin B
1
2012
36
0.020
 Why?
Intention to Treat Analysis
1
2012
77
0.020
 Why?
Tissue Donors
1
2015
405
0.020
 Why?
Candidiasis
1
2012
62
0.020
 Why?
Transplantation, Homologous
1
2013
416
0.020
 Why?
Mycobacterium avium Complex
1
2012
87
0.020
 Why?
Age Distribution
2
2003
397
0.020
 Why?
Hypoxia
1
2019
1166
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
344
0.020
 Why?
Cromolyn Sodium
2
2001
5
0.020
 Why?
Leukotriene Antagonists
1
2011
24
0.020
 Why?
Triazoles
1
2012
163
0.020
 Why?
Self Care
2
2005
392
0.020
 Why?
Functional Residual Capacity
1
2010
7
0.020
 Why?
Reference Values
1
2012
805
0.020
 Why?
Costa Rica
1
2010
18
0.020
 Why?
Colorado
1
2021
4599
0.020
 Why?
Principal Component Analysis
1
2011
197
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
205
0.020
 Why?
Health
1
2010
83
0.020
 Why?
Genome-Wide Association Study
1
2016
1406
0.020
 Why?
Inhalation
1
2010
29
0.020
 Why?
Environment
1
2011
341
0.020
 Why?
Observation
1
2008
56
0.020
 Why?
Sex Ratio
1
2008
15
0.020
 Why?
Least-Squares Analysis
1
2008
78
0.020
 Why?
Models, Econometric
1
2008
36
0.020
 Why?
Prospective Studies
2
2012
7787
0.020
 Why?
Health Services Administration
1
2007
8
0.020
 Why?
Treatment Refusal
1
2008
96
0.020
 Why?
Social Isolation
1
2007
65
0.020
 Why?
Intelligence
1
2007
134
0.020
 Why?
Puberty
1
2008
152
0.020
 Why?
Body Weight
1
2011
996
0.020
 Why?
Child Behavior Disorders
1
2007
142
0.020
 Why?
Exercise
1
2016
2108
0.010
 Why?
Insurance, Health
1
2007
298
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1113
0.010
 Why?
Genotype
1
2009
1865
0.010
 Why?
Bronchoconstrictor Agents
1
2003
14
0.010
 Why?
Organizational Innovation
1
2004
128
0.010
 Why?
Health Status Indicators
1
2004
161
0.010
 Why?
Case-Control Studies
1
2010
3580
0.010
 Why?
Systems Integration
1
2003
38
0.010
 Why?
Computer Systems
1
2003
52
0.010
 Why?
Motor Activity
1
2007
718
0.010
 Why?
Self Disclosure
1
2002
65
0.010
 Why?
Histamine H1 Antagonists
1
2002
28
0.010
 Why?
Drug Administration Schedule
1
2004
773
0.010
 Why?
Child Welfare
1
2004
228
0.010
 Why?
Administration, Intranasal
1
2002
91
0.010
 Why?
Confidence Intervals
1
2002
328
0.010
 Why?
Regression Analysis
1
2003
1015
0.010
 Why?
Nurse's Role
1
2003
167
0.010
 Why?
Point-of-Care Systems
1
2003
188
0.010
 Why?
Health Care Surveys
1
2002
562
0.010
 Why?
Sex Distribution
1
2001
381
0.010
 Why?
Patient Satisfaction
1
2004
691
0.010
 Why?
Linear Models
1
2002
855
0.010
 Why?
Disease Management
1
2003
632
0.010
 Why?
Decision Support Systems, Clinical
1
2003
263
0.010
 Why?
Caregivers
1
2007
940
0.010
 Why?
Bronchoscopy
1
2000
225
0.010
 Why?
Internet
1
2003
682
0.010
 Why?
Pregnancy
1
2010
7039
0.010
 Why?
Survival Analysis
1
2000
1323
0.010
 Why?
Infant, Newborn
1
2004
6262
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (18) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)